Abstract

Prion diseases are characterized by the accumulation of PrP<sup>Sc</sup>, an aberrantly folded isoform of the host protein PrP<sup>C</sup>. Specific forms of synthetic molecules known as dendrimers are able to eliminate protease-resistant PrP<sup>Sc</sup> in both an intracellular and in vitro setting. The properties of a dendrimer which govern this ability are unknown. We addressed the issue by comparing the in vitro antiprion ability of numerous modified poly­(propylene-imine) dendrimers, which varied in size, structure, charge, and surface group composition. Several of the modified dendrimers, including an anionic glycodendrimer, reduced the level of protease resistant PrP<sup>Sc</sup> in a prion strain-dependent manner. This led to the formulation of a new working model for dendrimer/prion interactions which proposes dendrimers eliminate PrP<sup>Sc</sup> by destabilizing the protein and rendering it susceptible to proteolysis. This ability is not dependent on any particular charge of dendrimer, but does require a high density of reactive surface groups

    Similar works

    Full text

    thumbnail-image

    Available Versions